Cuprina Holdings (Cayman) Ltd Ordinary Shares - Class A CUPR

Morningstar Rating
$1.76 −0.09 (4.86%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CUPR is trading at a LOCK|C><KSh premium.
Price
$1.76
Fair Value
LOCK|Jr!>n
Uncertainty
LOCK|@$ Z%#b!
1-Star Price
LOCK|RYrL&S
5-Star Price
LOCK|^dsc@M^
Economic Moat
LOCK|sw!&!
Capital Allocation
—

News

Trading Information

Previous Close Price
$1.85
Day Range
$1.60–1.79
52-Week Range
$1.45–14.80
Bid/Ask
$1.76 / $1.81
Shares Outstanding
7.65M
Market Cap
$12.33M
Volume/Avg
43,117 / 114,977

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
118.00
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
10

Valuation

Metric
CUPR
Price/Earnings (Normalized)
—
Price/Book Value
1.20
Price/Sales
118.00
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
CUPR
Quick Ratio
1.08
Current Ratio
2.35
Interest Coverage
−313.90
Quick Ratio
CUPR

Profitability

Metric
CUPR
Return on Assets (Normalized)
−64.47%
Return on Equity (Normalized)
−164.28%
Return on Invested Capital (Normalized)
−147.86%
Return on Assets
CUPR

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|Xlh$&?YLOCK|yD&$156B
Becton Dickinson & Co
BDX
LOCK|MHLOCK|Y<sS$58B
Alcon Inc
ALC
LOCK|z<J<by&LOCK|k$&G#$36B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|f^&nJmLOCK|#xG<$36B
ResMed Inc
RMD
LOCK|VdlK<m%?LOCK|^^<!$33B
West Pharmaceutical Services Inc
WST
LOCK|YB<wLchLOCK|#s$29B
Solventum Corp
SOLV
LOCK|CJGb?%BLOCK|Rs$15B
Baxter International Inc
BAX
LOCK|!dLOCK|gxG%$14B
Align Technology Inc
ALGN
LOCK|SmcR?wLOCK|fl>^S$12B
The Cooper Companies Inc
COO
LOCK|>YhCTQVLOCK|<qB%S$12B

Sponsor Center